Soricimed Biopharma Inc.
$66,978.00 CAD
≈ 10 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- September 15, 2020 – March 31, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q3-958701
Published purpose
The project includes preclinical studies required to advance SOR-C13, a clinical stage oncology drug, for the prevention and/or treatment of COVID-19 into clinical trials.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 10, 2026 from open.canada.ca Grants & Contributions